Dr.Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2020
NCT04505280
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Dr.Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi | Istanbul Dr. Lütfi Kırdar Şehir Hastanesi

Active Ingredients

Drugs in Other Trials (1)

lidocaine (xylocaine) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1